LSC Webinars CELL All

  1. De-Risking Cell Culture Media Scale-Up For Late-Stage Manufacturing 9/11/2026

    Explore practical approaches to scaling cell culture media manufacturing, from supply assurance to evolving quality requirements, digital formulation tools, and strategies for controlling costs.

  2. Beyond Breakdowns: Building A Culture Of Proactive Maintenance 9/8/2026

    Reactive maintenance can drive costly downtime, deviations, and reliability challenges. Learn how proactive maintenance strategies help improve equipment uptime and strengthen compliance.

  3. Building Robust Potency Assays 9/3/2026

    Robust potency assays depend on reliable biological readouts. Learn how quantitative protein expression analysis can provide sensitive, reproducible measurements of cellular responses.

  4. Enabling The Full Potential Of Process Chromatography 9/2/2026

    Real-time analytics can provide greater visibility into chromatography performance during scale-up, helping teams monitor purification, maintain critical process parameters and quality attributes.

  5. AI-Readiness In A Regulated World: A Practical Playbook For Life Sciences 9/2/2026

    Uncover how life science teams build defensible governance, maintain human oversight, and manage regulatory risks when adopting advanced digital tools.

  6. How To Define, Monitor, And Hit Critical Endpoints 8/26/2026

    Improve UF/DF repeatability by defining clear concentration and diafiltration endpoints, matching them with appropriate measurements, and applying real-time in-line analytics to reduce variability.

  7. Driving Measurable Productivity Gains In CHO Cell Culture 8/25/2026

    Explore how targeted media supplementation can improve CHO cell culture outcomes, simplify process optimization, and increase productivity across monoclonal antibodies and emerging modalities.

  8. Characterizing Process Performance And Robustness In An End-To-End Cryopreserved Autologous CAR-T/TCR Workflow 8/25/2026

    A systematic evaluation of an end-to-end cryopreserved CAR-T workflow examines how critical process parameters and unit operation interdependencies affect manufacturing consistency and robustness.

  9. CAR-T For Relapsed/Refractory AML 8/20/2026

    Explore how CD83-targeted CAR T cells may address a central challenge in AML treatment by suppressing malignant blasts while sparing healthy progenitor cells, with insights into antigen biology.

  10. Take The Turbulence Out Of Your Transfections 8/19/2026

    Run-to-run AAV titer variability can jeopardize production. Controlling incubation timing, DNA input, and media conditions improves yield and batch consistency.